Last reviewed · How we verify
Ascorbic Acid (Vitamin C) — Competitive Intelligence Brief
marketed
Vitamin / Essential micronutrient
Nutritional supplementation / General health
Small molecule
Live · refreshed every 30 min
Target snapshot
Ascorbic Acid (Vitamin C) (Ascorbic Acid (Vitamin C)) — New York Medical College. Ascorbic acid acts as a reducing agent and cofactor for enzymatic reactions, supporting collagen synthesis, immune function, and antioxidant defense.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ascorbic Acid (Vitamin C) TARGET | Ascorbic Acid (Vitamin C) | New York Medical College | marketed | Vitamin / Essential micronutrient |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Vitamin / Essential micronutrient class)
- New York Medical College · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ascorbic Acid (Vitamin C) CI watch — RSS
- Ascorbic Acid (Vitamin C) CI watch — Atom
- Ascorbic Acid (Vitamin C) CI watch — JSON
- Ascorbic Acid (Vitamin C) alone — RSS
- Whole Vitamin / Essential micronutrient class — RSS
Cite this brief
Drug Landscape (2026). Ascorbic Acid (Vitamin C) — Competitive Intelligence Brief. https://druglandscape.com/ci/ascorbic-acid-vitamin-c. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab